Andrew Platt - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Andrew Platt

This paper was not found in any repository, but could be made available legally by the author.

2024 Jonathan I. Silverberg

ORCID

, Marjolein de Bruin-Weller

ORCID

, Brian M. Calimlim

ORCID

ORCID

, Sarah A. Ofori

ORCID

, Andrew M. Platt

ORCID

, Henrique D. Teixeira

ORCID

, Kilian Eyerich

ORCID

, Jacob P. Thyssen

ORCID

Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis®

Upload

This paper is made freely available by the publisher.

Eric L. Simpson

ORCID

, Vimal H. Prajapati

ORCID

, Yael A. Leshem

ORCID

, Raj Chovatiya

ORCID

, Marjolein S. de Bruin-Weller

ORCID

, Sonja Ständer

ORCID

, Andrew E. Pink

ORCID

, Brian M. Calimlim

ORCID

ORCID

, Henrique Teixeira, Barry Ladizinski

ORCID

ORCID

ORCID

ORCID

, Meng Liu

ORCID

and 3 other authors

Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Jonathan I. Silverberg

ORCID

, Melinda J. Gooderham

ORCID

, Amy S. Paller

ORCID

, Mette Deleuran

ORCID

, Christopher G. Bunick

ORCID

, Linda F. Stein Gold, DirkJan Hijnen

ORCID

, Brian M. Calimlim

ORCID

ORCID

, Henrique D. Teixeira, Xiaofei Hu

ORCID

, Shiyu Zhang, Yang Yang

ORCID

ORCID

, Andrew M. Platt

ORCID

and 1 other authors

Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)

Upload

Missing publications? Search for publications with a matching author name.